[1]Marik PE, Gayowski T, Starzl TE.The hepatoadrenal syn-drome:a common yet unrecognized clinical condition[J].Crit Care Med, 2005, 33 (6) :1254-1259.
|
[2]Fede G, Spadaro L, Tomaselli T, et al.Assessment of adre-nocortical reserve in stable patients with cirrhosis[J].J Hep-atol, 2011, 54 (2) :243-250.
|
[3]O'Beirne J, Holmes M, Agarwal B, et al.Adrenal insuffi-ciency in liver disease–what is the evidence[J].J Hepa-tol, 2007, 47 (3) :418-423.
|
[4]Aravinthan A, Al-Naeeb Y, Richardson P, et al.Relativeadrenal insufficiency in a patient with liver disease[J].Eur JGastroenterol Hepatol, 2009, 21 (4) :471-473.
|
[5]Galbois A, Rudler M, Massard J, et al.Assessment of adre-nal function in cirrhotic patients:salivary cortisol should bepreferred[J].J Hepatol, 2010, 52 (6) :839-845.
|
[6]中华医学会肝病学分会, 中华医学会感染病学分会.慢性乙型肝炎防治指南[J], 中华肝脏病杂志, 2005, 13 (z1) :881-891.
|
[7]McCann VJ, Fulton TT.Cortisol metabolism in chronic liver dis-ease[J].J Clin Endocrinol Metab, 1975, 40 (6) :1038-1044.
|
[8]Tsai MH, Peng YS, Chen YC, et al.Adrenal insufficiency inpatients with cirrhosis, severe sepsis and septic shock[J].Hepatology, 2006, 43 (4) :673-681.
|
[9]Wiest R, Moleda L, Zietz B, et al.Uncoupling of sympathet-ic nervous system and hypothalamic-pituitary-adrenal axisin cirrhosis[J].J Gastroenterol Hepatol, 2008, 23 (12) :1901-1908.
|
[10]Arabi YM, Aljumah A, Dabbagh O, et al.Low-dose hydro-cortisone in patients with cirrhosis and septic shock:a random-ized controlled trial[J].CMAJ, 2010, 182 (18) :1971-1977.
|
[11]忠弼.病理学[M].北京:人民卫生出版社, 2006:405-419.
|
[12]Yaguchi H, Tsutsumi K, Shimono K, et al.Involvement ofhigh density lipoprotein as substrate cholesterol for steroido-genesis by bovine adrenal fasciculo-reticularis cells[J].Life Sci, 1998, 62 (16) :1387-1395.
|
[13]de la Llera-Moya M, Connelly MA, Drazul D, et al.Scav-enger receptor class B type 1 affects cholesterol homeostasisby magnifying cholesterol flux between cells and HDL[J].JLipid Res, 2001, 42 (12) :1969-1978.
|
[14]Thabut D, Tazi KA, Bonnefont-Rousselot D, et al.High dc-nsity lipoprotein administratjon attcnuates liver prolnflamma-tory response, restores liver endotheIial nitric oxide synthaseactivlty, and lowers portal pressure in cirrhotic rats[J].Hepa-tology, 2007, 46 (6) :1893-1906.
|